The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%.
Democrats Accuse Food Companies of Price Gouging
Democrats in Congress are looking into certain cereal, beverage, and snack manufacturers and whether they have been shrinking package sizes while keeping prices the same,